(Q38433161)

English

Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study

scientific article published on August 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

9

object named as

Ernst J Kuipers

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Miriam Sturkenboom

10

object named as

Miriam C J M Sturkenboom

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Vera E Valkhoff

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Eva M van Soest

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Giampiero Mazzaglia

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Mariam Molokhia

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

René Schade

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Gianluca Trifiro

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jay L Goldstein

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sonia Hernandez-Diaz

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2792-2802

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Guidelines for prevention of NSAID-related ulcer complications

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

International primary care classifications: the effect of fifteen years of evolution

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1002%2FART.34433

21 January 2018

Identifiers

10.1002/ART.34433

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38433161&oldid=1759621684"